EFFECT OF CANAGLIFLOZIN IN NON-DIABETIC OBESE PATIENTS WITH ALBUMINURIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Back
Abstract Number
WCN23-0397
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
EFFECT OF CANAGLIFLOZIN IN NON-DIABETIC OBESE PATIENTS WITH ALBUMINURIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Co-authors
Greeviroj, P.(1)*;Puapatanakul, P.(2);Phannajit, J.(2,3,4);Takkavatakarn, K.(2);Kittanamongkolchai, W.(2,5);Boonchaya-Anant, P.(1);Katavetin, P.(2);Praditpornsilpa, K.(2);Susantitaphong, P.(2,4);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Faculty Of Medicine- Chulalongkorn University, Division Of Endocrinology And Metabolism- Department Of Medicine, Bangkok, Thailand;(2)Faculty Of Medicine- Chulalongkorn University, Division Of Nephrology- Department Of Medicine, Bangkok, Thailand;(3)Faculty Of Medicine- Chulalongkorn University, Division Of Clinical Epidemiology- Department Of Medicine, Bangkok, Thailand;(4)Faculty Of Medicine- Chulalongkorn University, Research Unit For Metabolic Bone Disease In Ckd Patients, Bangkok, Thailand;(5)Faculty Of Medicine- Chulalongkorn University, Maha Chakri Sirindhorn Clinical Research Center Under The Royal Patronage, Bangkok, Thailand;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/b41e09e4842aafd1148db2477a5d569c.pdf
Audio File
if any